From sample-to-answer: integrated genotyping and immunological analysis microfluidic platforms for the diagnostic and treatment of coeliac disease

M. Jung; J. Höth; J. Erwes; D. Latta; X. Strobach; T. Hansen-Hagge; R. Klemm; C. Gärtner; T. M. Demiris; C. O'Sullivan; M. Ritzi-Lehnert; K. S. Drese

doi:10.1117/12.875314

14 February 2011 From sample-to-answer: integrated genotyping and immunological analysis microfluidic platforms for the diagnostic and treatment of coeliac disease

M. Jung, J. Höth, J. Erwes, D. Latta, X. Strobach, T. Hansen-Hagge, R. Klemm, C. Gärtner, T. M. Demiris, C. O'Sullivan, M. Ritzi-Lehnert, K. S. Drese

Author Affiliations +

Proceedings Volume 7929, Microfluidics, BioMEMS, and Medical Microsystems IX; 79290E (2011) https://doi.org/10.1117/12.875314
Event: SPIE MOEMS-MEMS, 2011, San Francisco, California, United States

Abstract

Taking advantage of microfluidics technology, a Lab-on-Chip system was developed offering the possibility of performing HLA (Human Leukocyte Antigen) typing to test genetic predisposition to coeliac disease and measure the level of immunodeficiency at the point-of-care. These analysis procedures are implemented on two different microfluidic cartridges, both having identical interfacial connections to the identical automated instrument. In order to assess the concentration of the targeted analytes in human blood, finger prick samples are processed to either extract genomic DNA carrying the coeliac disease gene or blood plasma containing the disease specific antibodies. We present here the different microfluidic modules integrated in a common platform, capable of automated sample preparation and analyte detection. In summary, this new microfluidic approach will dramatically reduce the costs of materials (polymer for the disposable chips and minute amount of bio-reagents) and minimize the time for analysis down to less than 20 minutes. In comparison to the state of the art detection of coeliac disease this work represents a tremendous improvement for the patient's quality of live and will significantly reduce the cost burden on the health care system.

Citation Download Citation

M. Jung, J. Höth, J. Erwes, D. Latta, X. Strobach, T. Hansen-Hagge, R. Klemm, C. Gärtner, T. M. Demiris, C. O'Sullivan, M. Ritzi-Lehnert, and K. S. Drese "From sample-to-answer: integrated genotyping and immunological analysis microfluidic platforms for the diagnostic and treatment of coeliac disease", Proc. SPIE 7929, Microfluidics, BioMEMS, and Medical Microsystems IX, 79290E (14 February 2011); https://doi.org/10.1117/12.875314

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available